Advances in Understanding Lipopolysaccharide-Mediated Hepatitis: Mechanisms and Pathological Features

Area of Science:

• Hepatology
• Immunology
• Microbiology

Background:

• Lipopolysaccharide (LPS) from Gram-negative bacteria is a critical factor in inflammatory liver disease.
• LPS triggers Kupffer cell activation via toll-like receptor 4 (TLR4) signaling, initiating inflammatory cascades.

Purpose of the Study:

• To review the multifaceted role of LPS in the pathogenesis of hepatic injury.
• To explore current and emerging therapeutic strategies for LPS-induced liver damage.

Main Methods:

• Review of scientific literature on LPS, Kupffer cells, TLR4 signaling, and hepatic inflammation.
• Analysis of pathological features and therapeutic interventions for LPS-induced liver injury.

Main Results:

• LPS activates Kupffer cells, inducing cytokines that cause hepatocyte apoptosis, endothelial damage, and thrombosis.
• Pathological hallmarks include hepatocyte shrinkage, sinusoidal expansion, and fibrin deposition.
• Aspirin, TLR4 pathway modulation, gut-liver axis regulation, and RNA interference show therapeutic potential.

Conclusions:

• LPS plays a dual role in promoting liver inflammation and thrombosis.
• Understanding LPS-driven mechanisms is crucial for managing hepatic inflammation and its systemic effects.
• Future research should focus on biomarkers, therapeutic optimization, and clinical safety.